Matches in Wikidata for { <http://www.wikidata.org/entity/Q37592456> ?p ?o ?g. }
- Q37592456 description "2016 թվականի հոկտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q37592456 description "article científic" @default.
- Q37592456 description "article scientifique" @default.
- Q37592456 description "articolo scientifico" @default.
- Q37592456 description "artigo científico" @default.
- Q37592456 description "artículu científicu espublizáu en 2016" @default.
- Q37592456 description "bilimsel makale" @default.
- Q37592456 description "scientific article published on 11 October 2016" @default.
- Q37592456 description "vedecký článok" @default.
- Q37592456 description "vetenskaplig artikel" @default.
- Q37592456 description "videnskabelig artikel" @default.
- Q37592456 description "vědecký článek" @default.
- Q37592456 description "wetenschappelijk artikel" @default.
- Q37592456 description "wissenschaftlicher Artikel" @default.
- Q37592456 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q37592456 description "научни чланак" @default.
- Q37592456 description "مقالة علمية نشرت في 11 أكتوبر 2016" @default.
- Q37592456 name "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 name "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 name "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 type Item @default.
- Q37592456 label "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 label "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 label "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 prefLabel "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 prefLabel "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 prefLabel "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 P1433 Q37592456-E96AED9B-CC20-450D-88E9-95508FB978EB @default.
- Q37592456 P1476 Q37592456-8AA5D290-9433-4384-846A-DF65FC3CA831 @default.
- Q37592456 P2093 Q37592456-0B2B028C-3268-431D-A3B9-CA5C02F12A45 @default.
- Q37592456 P2093 Q37592456-466DFD9F-8E4D-4C15-891D-A2F99EF8A06B @default.
- Q37592456 P2093 Q37592456-7918B23A-0CCA-4E25-8DCD-DC74CF6639AA @default.
- Q37592456 P2093 Q37592456-7C999458-5014-446E-98EF-B1049CEF098E @default.
- Q37592456 P2093 Q37592456-A9D8E3F7-9E8C-4E6F-91BD-5F4898C909C3 @default.
- Q37592456 P2093 Q37592456-B0067A8C-FEB2-4CB5-A614-CE7D6E4F35DF @default.
- Q37592456 P2093 Q37592456-C8A89BBF-132B-43A8-8DA5-1592A119A045 @default.
- Q37592456 P2093 Q37592456-DD3A83EF-EA96-46C9-9436-934A9362CBDE @default.
- Q37592456 P2093 Q37592456-F3F2AFBD-4D83-4343-ABAD-2F00B7E73DC1 @default.
- Q37592456 P2860 Q37592456-00119C11-83BD-4A17-B048-0EC0382A066B @default.
- Q37592456 P2860 Q37592456-0B5F425F-4490-4B72-8004-75FDEB1E0815 @default.
- Q37592456 P2860 Q37592456-0BB220C5-2752-4F48-9E99-E2D1CFBFB42E @default.
- Q37592456 P2860 Q37592456-14AC8EE6-3592-4BCC-ADAA-27AAFE550D14 @default.
- Q37592456 P2860 Q37592456-16E27FF2-AB85-4418-8B9D-D64356887972 @default.
- Q37592456 P2860 Q37592456-19A410B4-0B1F-4211-830F-6E9424FD2C14 @default.
- Q37592456 P2860 Q37592456-2337697D-E753-496C-8604-148245032441 @default.
- Q37592456 P2860 Q37592456-2535401D-828D-4632-9143-657F12114607 @default.
- Q37592456 P2860 Q37592456-2A46C353-D6DE-4940-B7C6-88D370C2BC6B @default.
- Q37592456 P2860 Q37592456-36087B7E-34E3-49AB-ACD7-FFF423CDE7DE @default.
- Q37592456 P2860 Q37592456-41E85D9C-ADAB-4F14-AF66-4D9163F1DA0A @default.
- Q37592456 P2860 Q37592456-454C5E06-D992-4A6A-AAAE-ACFF7B088E5F @default.
- Q37592456 P2860 Q37592456-46E13F15-4A43-471D-9E9B-14D291C1EBED @default.
- Q37592456 P2860 Q37592456-4A625267-F81C-45C8-856C-BC62B13B9E79 @default.
- Q37592456 P2860 Q37592456-5289B17B-9C6A-46CA-AA77-B3944B776EA2 @default.
- Q37592456 P2860 Q37592456-539844C7-2C6C-4D68-84C6-B0D48916158E @default.
- Q37592456 P2860 Q37592456-5893CD82-C135-4B5F-81E2-1FC420285467 @default.
- Q37592456 P2860 Q37592456-5C0355DE-4B16-476C-BF0B-2C0ED870F391 @default.
- Q37592456 P2860 Q37592456-6007C7C0-A366-4B2F-85D2-64902B995B88 @default.
- Q37592456 P2860 Q37592456-64738006-B7F7-4E8F-8706-76FEB0C086D8 @default.
- Q37592456 P2860 Q37592456-67F956B5-9AD5-4D8F-AFE7-0FBF146B4ED8 @default.
- Q37592456 P2860 Q37592456-6A185730-725C-47EC-8C0C-2C6AAC45099C @default.
- Q37592456 P2860 Q37592456-7BC109D5-A8E9-4A45-98C9-EB96942B5FF8 @default.
- Q37592456 P2860 Q37592456-7FDB65B3-8F4C-487E-A4C3-71AD61782145 @default.
- Q37592456 P2860 Q37592456-85F17F57-FA20-4D20-B1CE-3D6DC5825D4F @default.
- Q37592456 P2860 Q37592456-94917FC4-B70B-432B-83C1-649A450CE4B9 @default.
- Q37592456 P2860 Q37592456-94BC0796-685D-4933-B362-87365F276D86 @default.
- Q37592456 P2860 Q37592456-9799068D-4675-466B-B0A5-F6B05420129C @default.
- Q37592456 P2860 Q37592456-9AA62A92-4A9B-47F0-A266-3D426F80523D @default.
- Q37592456 P2860 Q37592456-9D5F7261-6FE0-45C3-96D1-04349C8ACEA4 @default.
- Q37592456 P2860 Q37592456-9EEF4749-9E54-4635-A4F6-7F1459A99341 @default.
- Q37592456 P2860 Q37592456-ABA07BBF-64DD-470F-9D16-A2340F7DC7DA @default.
- Q37592456 P2860 Q37592456-ADFCA213-9A53-4FAA-A1B9-F4F0203D8FBE @default.
- Q37592456 P2860 Q37592456-B8B38BBC-4BA5-4485-8590-FCF3DACF9B64 @default.
- Q37592456 P2860 Q37592456-C9698663-25AD-400B-AA19-956C0A34EFFC @default.
- Q37592456 P2860 Q37592456-E279B768-CE58-4A29-99C6-DA203115BCE3 @default.
- Q37592456 P2860 Q37592456-E6939EA0-C256-4331-AB21-807EC2E00B63 @default.
- Q37592456 P2860 Q37592456-ED6549F0-478B-41A2-8BBC-989AB0AA9C8B @default.
- Q37592456 P2860 Q37592456-EF1EE0B2-19C7-444E-B8AF-83C833E1A192 @default.
- Q37592456 P2860 Q37592456-FE268399-610C-4BD3-8ACF-A73C79989B86 @default.
- Q37592456 P304 Q37592456-6C242D45-4BD1-4CD3-8AD8-00C345F0D178 @default.
- Q37592456 P31 Q37592456-4A565015-5B20-44AF-A48D-D671FC2838CB @default.
- Q37592456 P356 Q37592456-24E69FF2-AB2D-491B-8954-790B50A740B6 @default.
- Q37592456 P433 Q37592456-9EDBDFBD-5D1F-4813-929C-CEE074BA9B25 @default.
- Q37592456 P478 Q37592456-B8A741E5-7574-4DFC-AD62-885C0A0D340A @default.
- Q37592456 P50 Q37592456-96A62C87-8A64-4FF9-B8E6-EC230D1A576A @default.
- Q37592456 P577 Q37592456-DCE34D82-1D8A-4F3F-ADBD-E3A76B5A9897 @default.
- Q37592456 P698 Q37592456-B32B381B-E2B0-43BC-9EF4-289D8E3B42C5 @default.
- Q37592456 P921 Q37592456-903435C9-FA15-401C-B13C-47B36E4C2DD7 @default.
- Q37592456 P932 Q37592456-22A3F86F-CA78-4E7B-9F1E-6ED851CF31B5 @default.
- Q37592456 P356 NMC.OA.2016-0162 @default.
- Q37592456 P698 27725524 @default.
- Q37592456 P1433 Q26842870 @default.
- Q37592456 P1476 "Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group" @default.
- Q37592456 P2093 "Koichi Iwasaki" @default.
- Q37592456 P2093 "Masashi Oda" @default.
- Q37592456 P2093 "Namiko Nishida" @default.
- Q37592456 P2093 "Nobuhiro Mikuni" @default.
- Q37592456 P2093 "Susumu Miyamoto" @default.
- Q37592456 P2093 "Tetsuya Tsukahara" @default.
- Q37592456 P2093 "Tetsuya Ueba" @default.
- Q37592456 P2093 "Tomokazu Aoki" @default.